Developing Risk-Based Testing Strategies for Advanced Therapies
Although the advanced therapies industry is not new, no harmonised testing standards are currently available to align the industry.
Although the advanced therapies industry is not new, no harmonised testing standards are currently available to align the industry.
Virtually everyone in a study in the United Kingdom who had COVID-19 still had antibodies to it in their systems three months after recovering, and almost nine in 10 had them after six months.
An Interview with Ward Carter, Chief Operating Officer, QualTex Laboratories
Test detects antibodies developed during a COVID-19 infection QualTex Laboratories, a subsidiary of San Antonio-based nonprofit BioBridge Global, has begun offering the Ortho Diagnostics VITROS® Anti-SARS-CoV-2 IgG assay
Lab to support researchers developing new treatments for global healthcare market QualTex Laboratories, a subsidiary of San Antonio-based nonprofit BioBridge Global, has expanded its offerings
Partners will develop potency assay for mesenchymal stromal cells The federal Medical Technology Enterprise Consortium (MTEC) has identified the need for potency testing as critical
Community Labs soon will be performing up to 10,000 COVID-19 tests a day and expects to reach capacity of 20,000 or more per day by January.
Independent blood centers from coast to coast are facing critical shortages, according to information compiled by their trade association. Of the 59 organizations in America’s
COVID-19 testing facility based at BioBridge Global receives $1 million boost Getting the Community Labs COVID-19 testing program up and running in just three months is a
Beginning Monday, October 5, the City of San Antonio’s no cost testing sites will have a soft launch to expand testing to asymptomatic individuals. The
Despite 150 years of research, major roadblocks keep scientific ‘Holy Grail’ out of reach.
New Emergency Use Authorization could make COVID-19 therapy more readily available to coronavirus patients The Food and Drug Administration has changed the status of COVID-19